Literature DB >> 12637843

American attitudes toward and willingness to use psychiatric medications.

Thomas W Croghan1, Molly Tomlin, Bernice A Pescosolido, Jason Schnittker, Jack Martin, Keri Lubell, Ralph Swindle.   

Abstract

Despite recent advances in treatment, many Americans decline to take prescribed psychiatric medication. This study explores the role of attitudes regarding the effectiveness of and potential problems associated with psychiatric medications on Americans' willingness to use them. Face-to-face interviews of a US household population sample were done with 1387 volunteers. The 1998 General Social Survey's (response rate, 76.4%) included questions about efficacy, problems, and potential use. Most Americans agree that psychiatric medications are effective, and fewer than half had concerns regarding potential problems. However, the majority of respondents would not be willing to take them. Willingness to use is influenced by these attitudes and other factors, including health status and past use of mental health treatments. Although Americans perceive psychiatric medications to be effective, and this influences their willingness to take them, many still are not willing to take them.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12637843     DOI: 10.1097/01.NMD.0000054933.52571.CA

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  29 in total

1.  Mental health service use 1-year after the World Trade Center disaster: implications for mental health care.

Authors:  Joseph A Boscarino; Richard E Adams; Charles R Figley
Journal:  Gen Hosp Psychiatry       Date:  2004 Sep-Oct       Impact factor: 3.238

2.  Can a self-referral system help improve access to psychological treatments?

Authors:  June S L Brown; Jed Boardman; Naureen Whittinger; Mark Ashworth
Journal:  Br J Gen Pract       Date:  2010-05       Impact factor: 5.386

3.  Who Comes Out With Their Mental Illness and How Does It Help?

Authors:  Patrick W Corrigan; Patrick J Michaels; Karina Powell; Andrea Bink; Lindsay Sheehan; Annie Schmidt; Bethany Apa; Maya Al-Khouja
Journal:  J Nerv Ment Dis       Date:  2016-03       Impact factor: 2.254

4.  Attitudes toward mental illness in adults by mental illness-related factors and chronic disease status: 2007 and 2009 Behavioral Risk Factor Surveillance System.

Authors:  Rosemarie Kobau; Matthew M Zack
Journal:  Am J Public Health       Date:  2013-09-12       Impact factor: 9.308

5.  Public conceptions of serious mental illness and substance abuse, their causes and treatments: findings from the 1996 general social survey.

Authors:  Sara Kuppin; Richard M Carpiano
Journal:  Am J Public Health       Date:  2006-10       Impact factor: 9.308

6.  WPA guidance on how to combat stigmatization of psychiatry and psychiatrists.

Authors:  Norman Sartorius; Wolfgang Gaebel; Helen-Rose Cleveland; Heather Stuart; Tsuyoshi Akiyama; Julio Arboleda-Flórez; Anja E Baumann; Oye Gureje; Miguel R Jorge; Marianne Kastrup; Yuriko Suzuki; Allan Tasman
Journal:  World Psychiatry       Date:  2010-10       Impact factor: 49.548

7.  Public conceptions of serious mental illness and substance abuse, their causes and treatments: findings from the 1996 General Social Survey.

Authors:  Sara Kuppin; Richard M Carpiano
Journal:  Am J Public Health       Date:  2008-09       Impact factor: 9.308

Review 8.  Symbiotic relationship of pharmacogenetics and drugs of abuse.

Authors:  Joni L Rutter
Journal:  AAPS J       Date:  2006-03-24       Impact factor: 4.009

Review 9.  The public stigma of mental illness: what do we think; what do we know; what can we prove?

Authors:  Bernice A Pescosolido
Journal:  J Health Soc Behav       Date:  2013-01-16

10.  Attitudes about stimulant medication for attention-deficit/hyperactivity disorder among African American families in an inner city community.

Authors:  Susan dosReis; Arlene Butz; Paul H Lipkin; Julia S Anixt; Courtney L Weiner; Robin Chernoff
Journal:  J Behav Health Serv Res       Date:  2006-10       Impact factor: 1.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.